Solidifying its position as a global leader in the field of handling and storage of pharmaceutical products and vaccines across all temperature ranges, Abu Dhabi Ports’ Logistics, a subsidiary of AD Ports Group, has been awarded the coveted Good Distribution Practice (GDP) accreditation by one of the world’s leading testing, inspection, and certification bodies.

Robert Sutton, Head of Logistics Cluster, AD Ports Group; receiving the GDP Accreditation Certificate from Bureau Veritas representative in the presence of a number of the Group’s officials.

The award was issued by Bureau Veritas, which certified AD Ports’ advanced pharmaceutical cold and ultra-cold storage facility in the Khalifa Industrial Zone Abu Dhabi (KIZAD) and its related logistical services, against both European Union and World Health Organisation (WHO) guidelines. The announcement marks the first instance a UAE organisation has secured accreditation for both standards and is one of the few in the Middle East to hold that distinction.

The GDP accreditation certifies that all required measures designed to safeguard product quality and reduce risk have been implemented and are being followed along the entire pharma cold and non-cold chain journey. Ultimately, adherence to such high standards ensures customers that pharmaceutical products they receive through the healthcare vertical of Abu Dhabi Ports Logistics can maintain their quality and efficacy.

Captain Mohamed Juma Al Shamisi, Group CEO, AD Ports Group, said: “Since its founding, AD Ports Group has worked to establish itself as a world leader in trade, industry, and logistics. Today’s announcement represents an important building block in helping realise our Government’s vision of making Abu Dhabi a major global healthcare and life sciences hub. We now hold the distinction as being the first healthcare organisation in the UAE to be GDP certified against the EU and WHO standards for pharmaceutical and medical supply distribution, and one of the few in the Middle East to hold both.

“Rather than resting on our laurels, we aim to continue elevating our healthcare logistics and pharma cold and non-cold chain service capabilities to new heights and to continue supporting the growth of Abu Dhabi’s and the UAE’s fast-developing healthcare sector.”

Comments are closed.